Cargando…
Dab2 attenuates brain injury in APP/PS1 mice via targeting transforming growth factor-beta/SMAD signaling
Transforming growth factor-beta (TGF-β) type II receptor (TβRII) levels are extremely low in the brain tissue of patients with Alzheimer's disease. This receptor inhibits TGF-β1/SMAD signaling and thereby aggravates amyolid-beta deposition and neuronal injury. Dab2, a specific adapter protein,...
Autores principales: | Song, Lei, Gu, Yue, Jie, Jing, Bai, Xiaoxue, Yang, Ying, Liu, Chaoying, Liu, Qun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4146324/ https://www.ncbi.nlm.nih.gov/pubmed/25206742 http://dx.doi.org/10.4103/1673-5374.125328 |
Ejemplares similares
-
VIP Enhances Phagocytosis of Fibrillar Beta-Amyloid by Microglia and Attenuates Amyloid Deposition in the Brain of APP/PS1 Mice
por: Song, Min, et al.
Publicado: (2012) -
Codonopsis pilosula polysaccharide attenuates Aβ toxicity and cognitive defects in APP/PS1 mice
por: Wan, Lu, et al.
Publicado: (2020) -
RNAi-mediated knock-down of Dab and Numb attenuate Aβ levels via γ-secretase mediated APP processing
por: Xie, Zhongcong, et al.
Publicado: (2012) -
To Dab or Not to Dab: Rising Concerns Regarding the Toxicity of Cannabis Concentrates
por: Alzghari, Saeed K, et al.
Publicado: (2017) -
Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice
por: Gong, Zhuo, et al.
Publicado: (2019)